Towards quantitative and multiplexed in vivo functional cancer genomics

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Large-scale sequencing reveals numerous genomic alterations in human tumors.
• Genetically engineered mouse models are crucial for understanding cancer-associated genetic changes.
• The functional significance of most cancer genomic aberrations remains largely unknown due to limitations of current models.

Purpose of the Study:

• To accelerate the functional interrogation of cancer-associated genomic alterations in vivo.
• To overcome the time, cost, and labor limitations of traditional genetically engineered mouse models.
• To enable a broader understanding of the biological meaning of genomic aberrations in cancer.

Main Methods:

• Utilizing CRISPR-Cas9-based strategies for rapid generation of somatic alterations.
• Employing multiplexed and quantitative approaches for in vivo gene function ascertainment.
• Leveraging advanced in vivo models for functional studies of cancer genomics.

Main Results:

• Recent advances have significantly accelerated the functional analysis of cancer-associated alterations.
• CRISPR-Cas9 technologies enable rapid creation of complex somatic alterations.
• Multiplexed and quantitative methods enhance the ability to determine gene function in vivo.

Conclusions:

• New technologies are rapidly advancing the functional study of cancer genomics.
• The functional importance of the majority of genomic aberrations in cancer is becoming increasingly clear.
• These advancements promise to broaden the utility of in vivo models for cancer research.